use concentrated growth factor.
Phase 2Small molecule
use concentrated growth factor. is one of 36 small molecule programs targeting Recurrent aphthous stomatitis. It is currently in Phase 2.
2
Indications
2
Total Trials
0
Active Trials
35
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
364 competitors in Growth
#DrugCompanyPhaseTrials
1Lovenox
SanofiPreclinical
Aricept
EisaiPreclinical
Zolymbus
AbbViePreclinical
Zyloprim
Alnylam PharmaceuticalsPreclinical
Somavaratan
Novo NordiskPreclinical
use concentrated growth factor.
TTanta University
Phase 2
Accutane
CConrado Roberto Hoffmann Filho
Preclinical
Glucagon
XXeris Pharmaceuticals
Preclinical
Prilosec
DDexcel Pharma Technologies Ltd.
Preclinical
Trental
VValidus Pharmaceuticals
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- TTanta University